Introduction
============

Chemical biocides have been used for centuries, originally for food and water preservation, although there are early accounts of their use for wound management ([@b93]; [@b40]; [@b163]). A clear landmark in the use of biocides in the healthcare setting was the advent of antisepsis and the use of chlorine water in the early 19th century ([@b135], [@b136]). The 20th century witnessed a tremendous increase in the number of active compounds being used for disinfection, sterilization, and preservation, with the development of cationic biocides such as biguanides and quaternary ammonium compounds (QACs), phenolics, aldehydes, and peroxygens ([@b140]). The same chemical agent can be used for different applications, the main difference being the concentration at which it is employed. For example, the biguanide chlorhexidine is used for surface disinfection at 0.5%--4% volume/volume (v/v), for antisepsis at 0.02%--4% v/v and for preservation at a concentration of 0.0025%--0.01% v/v. The concentration of a biocide within a formulation or product is of prime importance for its antimicrobial activity, although there needs to be a balance between efficacy (ie, destroying microorganisms) and toxicity. In hospital settings, 3 levels of disinfection are recognized (high-, intermediate-, and low-level) depending upon the risk of microbial survival and transmission to patients ([@b154], [@b155], [@b156], [@b157]). Hospital disinfection policies have a major role to play in the control of hospital-associated infections (HAIs) ([@b152], [@b153]; [@b154], [@b156]; [@b117]; [@b55]). The increased usage of products containing low concentrations of commonly used biocides, such as phenolics and cationic compounds, has raised some concerns ([@b90]; [@b42]) about their overall efficacy, but also about the possible emergence of microbial resistance. Indeed, there are now multiple laboratory reports about the emergence of bacterial resistance to biocides, often as a result of exposure to a lower (sublethal) concentration ([@b113]; [@b177]; [@b184], [@b185]; [@b33]; [@b143], [@b145]; [@b192]). The possible development of bacterial resistance (not only to biocides, but also to antibiotics), the benefit of biocide usage, and their possible role in the emergence of multidrug-resistant bacteria, add further questions to the extensive use of biocidal products ([@b89]; [@b141], [@b142], [@b143]; [@b148]; [@b162]; [@b16]). The benefits and disadvantages of biocide usage in the healthcare environment need to be carefully considered.

Biocides usage and activity
===========================

Biocides -- usage and policies
------------------------------

Biocides are used extensively in healthcare settings for different applications: the sterilization of medical devices; the disinfection of surfaces and water; skin antisepsis; and the preservation of various formulations. In addition, there are now numerous commercialized products containing low concentrations of biocides, the use of which is controversial. Some professionals believe that the indiscriminate usage of biocides in the healthcare environment may not be justified and is detrimental in the long term, for example, by promoting the emergence of bacterial resistance to specific antimicrobials ([@b151]; [@b89], [@b90]; [@b142], [@b144]; [@b148]; [@b162]; [@b16]; [@b42]). The indiscriminate use of disinfectants in the hospital environment is not a new problem as it was raised in the 1960s ([@b6]), but it remains a current issue. There are diverging opinions regarding the use of biocide formulations and products for noncritical surface disinfection. While some view such use as unnecessary ([@b55]), others support such a practice ([@b156]). The use of biocidal products may be more appropriate only in specific situations where the risk of spreading HAIs is high ([@b17]; [@b145]). Some surfaces may only need cleaning and do not require chemical disinfection as they are rarely heavily contaminated ([Table 1](#tbl1){ref-type="table"}), whereas other medical articles need thorough cleaning with detergents and chemical disinfection, eg, wash boils, bedpans, urinal ([Table 1](#tbl1){ref-type="table"}). Thorough cleaning, washing, and drying have been shown to limit the risk of infection ([@b11]). Flexible endoscopes are of particular interest, since they are now used for a wide range of diagnostic and therapeutic procedures. Gastrointestinal endoscopes and bronchoscopes are often grossly contaminated and require special sterilization regimens involving chemical disinfectants as these medical devices are often heat sensitive. Several biocides are used for the high-level disinfection of these devices in specially designed automated machines, which clean, disinfect, and rinse the lumens and external surfaces of the flexible endoscopes. The biocides of choice are glutaraldehyde and *ortho-*phthalaldehyde, peracetic acid, alcohol, peroxygen products, chlorine dioxide, and superoxidized water for the main ones ([@b12]) ([Table 2](#tbl2){ref-type="table"}). Guidelines are available from professional societies regarding the appropriate immersion time and risk assessment ([@b21]). Overall, the incidence of post-procedural infection appears low ([@b55]). There are some reports describing the washer-disinfectors as a source of instrument contamination when the concentration of the high-level disinfectant is too low ([@b186]; [@b63]), or when biofilms are present (eg, following a lack of cleaning and maintenance) ([@b10]; [@b123]).

###### 

Treatment of the hospital environment and equipment

  Environment/Equipment                                    Comments                                                                                                                                 Treatment
  -------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Walls, ceiling                                           Rarely heavily contaminated (surfaces need to remain dry)                                                                                Occasional cleaning and drying. Chemical disinfection
                                                           Occasional spillages                                                                                                                     
  Floors[a](#tf1-1){ref-type="table-fn"}                   More heavily contaminated; only a small proportion are potential pathogens. Related to the activity on the ward (eg, number of people)   Cleaning with detergents. Disinfection recommended only in high-risk areas
  Baths                                                    Many bacteria remain on the surface after emptying the bath                                                                              Thorough cleaning with detergents. Disinfection necessary in maternity and surgical units where multiresistant bacteria might be present
  Washbowls                                                High number of bacteria can grow if not dried properly                                                                                   Thorough cleaning and drying
  Toilets                                                  Potential risk during gastrointestinal infection                                                                                         Thorough cleaning with detergents, except during infection outbreaks for which chemical disinfection might be indicated
  Bedpans and urinals                                      Potential risk during gastrointestinal infection                                                                                         Thermal disinfection recommended
  Crockery and cutlery                                     Heavily contaminated after handwash processing                                                                                           Washing in a machine with minimal temperature of 50--60°C recommended
  Cleaning equipment                                       Floor mops heavily contaminated                                                                                                          Heat disinfection recommended. Immersion in chemical disinfectants should be avoided
  Babies\' incubator                                       Rarely heavily contaminated but high risk of transmission                                                                                Thorough cleaning and drying of surfaces. Chemical disinfection might be considered
  Respiratory ventilators                                  Accumulation of moisture associated with bacterial growth                                                                                Changing reservoir bag, tubing and connectors every 48 hours. Heat disinfection for respiratory circuits recommended. Use of heat-moisture exchangers or filters recommended. Use of washer--disinfectors for reusable circuits
  Anesthetic equipment                                     Machines rarely heavily contaminated providing that the associated tubing is regularly changed                                           Low temperature steam or washing-machine (70--80°C) for corrugated tubing. Single use circuit preferred in some cases. Chemical disinfection to be avoided
  Endoscopes                                               May be heavily contaminated                                                                                                              High-level disinfection for flexible heat sensitive endoscopes. Heat or gaseous sterilization for rigid devices
  Vaginal specula and other vaginal devices                Potential risk of acquiring viral infection                                                                                              Single use items are preferred. Heat sterilization recommended
  Tonometers                                               Potentially risk of viral transmission                                                                                                   Chemical disinfection required[b](#tf1-2){ref-type="table-fn"}
  Stethoscopes                                             Some reports of staphylococci transmission                                                                                               Thorough regular cleaning with 70% alcohol recommended
  Sphygmomanometer                                         Some reports of staphylococci transmission                                                                                               Thorough washing and drying of contaminated cuff.
  Linen                                                    May be heavily contaminated                                                                                                              Heat (65°C) for heat-stable linen. Chemical disinfection in penultimate rinse, laundering at 40°C and dry at 60°C for heat-sensitive linen
  Dressing trolleys, mattress covers, supports, curtains   May require decontamination                                                                                                              Thorough cleaning necessary. Decontamination by heat preferable to chemical disinfection

Carpets may add additional problems ([@b146])

In case of potential transmission of spongiform encephalopathy, disposable tonometer head should be used.

NOTE: Table compiled from information from [@b7]; [@b152], [@b153]; [@b154], [@b157]; [@b54], [@b55]; [@b117].

The treatment of air is particularly challenging and is rarely considered necessary in hospitals, although the [@b46]) recommends good ventilation with filtered air for operating theatres, isolation rooms, and safety cabinets. In addition, prevention of airborne contaminants, particularly from the environment, is important through regular maintenance and use of biocidal treatment of static water, etc, for example to prevent the onset of *Legionella* ([@b47]; [@b67]).

The principles of disinfection policy in healthcare facilities has been described in several reports, by [@b152], [@b153]), [@b7]), and more recently by [@b54], [@b55]). Disinfection policies should take into account the reasons and purposes for which disinfectants are used, the risk of infection from equipment, or the environment and implementations of such policies ([Table 2](#tbl2){ref-type="table"}) ([@b55]). The benefits of the introduction of comprehensive disinfection policies on the reduction of HAIs have been described ([@b108]), although their implementation has sometimes been perceived as unsatisfactory ([@b26]; [@b81]; [@b166]). For example, infection control is an important element of safe dental practice. Chemical biocides together with detergents are used for the disinfection of surfaces ([@b114]) that can become contaminated with blood and saliva ([@b98]), and for the disinfection of impressions, prosthetic, and orthodontic appliances. However, a recent survey showed that a large number of dental practices have no written policies on disinfection and sterilization procedures ([@b13]). The lack of standard infection control measures has been blamed for HAIs ([@b117]; [@b157]; [@b176]).

###### 

Principles of disinfection policies

  ------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Objectives and purposes*                                                      To prevent infection but in practical terms to reduce the bioburden to a level at which infection is unlikely. Need to consider the standard of hygiene expected by patients and staff
  *Categories of risk for patients and treatment of equipment and environment*   
  High risk                                                                      Sterilization by heat or other methods (eg, ethylene oxide; low temperature steam formaldehyde); high-level disinfection may be acceptable (eg, GTA, OPA, PAA)
  Intermediate risk                                                              Disinfection
  Low risk                                                                       Cleaning and drying usually sufficient; disinfection
  Minimal risk                                                                   Cleaning and drying; disinfection in case of contaminated spillage
  *Requirements of chemical disinfectants*                                       
  Spectrum of activity                                                           "cidal" rather than "static" activity
  Efficacy                                                                       Rapid action, notably on surfaces
  Incompatibility                                                                should not be neutralized/quenched easily, eg, by hard water, soap, organic load
  Toxicity                                                                       Should be minimal
  Damages to products/surfaces Costs                                             Corrosiveness should be minimal, especially at in use dilution. Should not damage the surface/articles to be disinfected, eg, endoscopes should be acceptable and supplies assured
  *Implementations of the disinfection policies*                                 
  Organization                                                                   Infection control team should be responsible. Need clear cut and well defined responsibilities
  Training                                                                       End users (nursing and domestic staff) should be trained appropriately. Clear schedules and supervision by trained staff should be in place.
  Distribution and dilution                                                      Staff training is essential. Suitable dispensers of disinfectants should be available
  Testing of disinfectants                                                       Need to be properly documented and assessed preferably by an independent organisation following standard protocols.
  Costs                                                                          Should be considered carefully
  ------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** GTA, glutaraldehyde; OPA, *ortho*-phthalaldehyde; PAA, peracetic acid.

Biocides -- alteration of activity
----------------------------------

The activity of a biocide depends upon a number of factors ([Table 3](#tbl3){ref-type="table"}), some inherent to the biocide, some to microorganisms. Among microorganisms most resistant to biocidal exposure are bacterial spores, followed by mycobacteria, Gram-negative, Gram-positive, and fungal microorganisms. The sensitivity of viruses usually depends upon their structure, but notably also depends on whether they possess an envelope ([@b106]), enveloped viruses being more sensitive to disinfection ([@b104]). Although there are exceptions within this summarized classification (eg, some mycobacteria are relatively sensitive to disinfection), this attempt at distinguishing microorganisms according to their susceptibility to biocides gives useful information for the selection of an appropriate biocidal agent ([@b149]). However, it is not always possible to predict which microorganisms will be present on certain surfaces, although the organic load or the extent of microbial contamination, and the presence or not of a biofilm, can be anticipated ([@b54]; [@b154]). An understanding of the factors affecting antimicrobial activity is essential to ensure that a biocidal product/formulation is used properly ([@b146]). As mentioned in the introduction, a biocide\'s concentration is probably the most important factor to affect antimicrobial activity ([Table 3](#tbl3){ref-type="table"}) ([@b147]). Poor understanding of the concentration exponent can lead to microbial survival on surfaces, but also in products, and thus to infection or spoilage. Bacterial survival in biocidal formulations, notably containing QACs, has been described since the 1950s\' and has been linked to inappropriate usage ([@b168]; [@b133]; [@b51]; [@b79]), for example, a decrease in active concentration ([@b186]) or the incorporation of low concentrations in medical devices such as catheters ([@b171]; [@b173]). Bacteria resistant to all known preservatives have also been reported ([@b29]; [@b31]). Exposure/treatment time is also essential. Standard efficacy tests often recommend a minimal contact time, such as 1 min for the testing of hygienic handwash ([@b27]) or 5 min for the testing of disinfectants and antiseptics ([@b28]). Decreasing exposure time is often associated with a decrease in activity, which is exemplified from kinetic inactivation studies ([@b178]; [@b56]; [@b192]). Other important factors relate to the conditions in which a product is employed, mainly the presence of organic materials (which will inactivate certain biocides), or the concurrent use of a quenching agent, eg, combining a cationic agent with an anionic surfactant ([Table 3](#tbl3){ref-type="table"}) ([@b146]), or the use of emollient after hand washing ([@b190]; [@b14]). On this latter point, information available on the effect of hand care product is sometimes contradictory. Indeed, [@b71] reported that the use of hand care products did not affect the antimicrobial efficacy of hand rub formulations, although, in this case, a very limited number of products were tested. In addition, the effect of temperature on biocidal activity is important to understand in specific situations, for example, where biocidal efficacy relies upon a combination of chemical inactivation and elevated temperature (eg, certain sterilization process; automated washer-disinfector), or when a preservative-containing formulation is stored at a low temperature. Finally, pH might not be as important here as it will affect mainly the formulation (thus a concern for the manufacturer), but should not change drastically during use. It has to be noted that a change of pH can alter the biocide\'s ionization and hence its activity, the growth of the microorganisms, and its overall surface charge, eg, increasing pH enhances the activity of cationic biocides ([@b146]). Understanding these factors is essential and the appropriate training of end users, ie, nursing and domestic staff, is important to ensure that the efficacy of a biocidal product/formulation is maintained ([@b196]).

###### 

Factors influencing the antimicrobial activity of biocides

  Factors[a](#tf3-1){ref-type="table-fn"}   Comments                                                                                                                  Relevance and consequence in practice
  ----------------------------------------- ------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------
  *Factors inherent to the biocide*                                                                                                                                   
  Concentration                             Understand the concentration exponent (ie, the effect of dilution upon activity)                                          Appropriate staff training required
  Contact time                              Longer contact time often associated with increased activity                                                              Appropriate staff training required
  Organic load                              Quench the activity of a biocide or protect microorganisms                                                                Combination of physical (cleaning) and chemical action required
  Formulation                               Possible inactivation of biocide                                                                                          Understand the nature of the active agent
  Temperature                               Important for some devices (eg, endoscope washer)                                                                         Important to understand that adequate staff training is required with certain types of equipment
  pH                                        Affect both the biocide (stability and ionisation) and the microorganism (growth and electric charge)                     Probably not as important in the healthcare environment
  *Factors inherent to the cell*                                                                                                                                      
  Presence of biofilm                       Dormant "persister" cells difficult to eradicate. Likely to be present on equipment, certain surfaces                     Combination of physical (cleaning) and chemical action required
  Type of microorganisms                    Will affect the choice of the agent to use. Bacterial spores: the most resistant; envelope viruses: the least resistant   Evaluation of the possible type of biocide needed
  Number of microorganisms                  High number more difficult to eradicate                                                                                   Biocides often used in high (ie, excess) concentration. High number of cells might not be a problem

Factors listed in order of importance.

Problems associated with the use of biocides
============================================

The emergence of bacterial resistance to biocides and the possible linkage between biocide and antibiotic resistance is a major topic of discussion and concern. The emergence of bacterial resistance to biocides is not a new phenomenon and has been described since the 1950s, particularly with products containing a cationic biocide ([@b145]). More recently, the emergence of bacterial resistance to biocides to low (inhibitory) concentrations has been widely reported, mainly from laboratory studies, but also from environmental investigations.

Emergence of bacterial resistance -- evidence from laboratory investigations
----------------------------------------------------------------------------

Investigating the possible emergence of bacterial resistance to various biocides is a topical subject and reports can easily be found in the literature, notably on the understanding of the basis of such resistance. Low to intermediate levels of resistance have been observed in most cases, although from time to time high-level resistance has been reported, eg, with the bisphenol triclosan ([@b159]; [@b68], [@b70]), or with the chemosterilant glutaraldehyde ([@b63]; [@b109]; [@b56]; [@b191]), and oxidizing agents ([@b50]).

There is now a better understanding of the overall mechanisms that enable bacteria to withstand exposure to low concentrations of a biocide ([Table 4](#tbl4){ref-type="table"}) ([@b131]; [@b35]). As mentioned earlier, some microorganisms are better at surviving a biocidal treatment than others, primarily through their intrinsic properties and impermeability. The impermeability barrier, encountered in spores ([@b139]; [@b149]; [@b35]), but also in vegetative bacteria such as mycobacteria, and to some extent, Gram-negative bacteria, limits the amount of a biocide that penetrates within the cell ([@b105]; [@b83]). The role of specific cell structure, such as lipopolysaccharides (LPS) in Gram-negative bacteria ([@b45]) and the mycoylarabinogalactan layer in mycobacteria ([@b83]), in this resistance mechanism has been demonstrated by the use of permeabilizing agents such as ethylenediamine tetraacetic acid (EDTA) ([@b9]; [@b99]; [@b45]), or organic acids ([@b8]; [@b9]), and cell wall inhibitors such as ethambutol ([@b22]; [@b191]). The insusceptibility of Gram-negative bacteria to biocidal agents can be decreased further by a change in overall hydrophobicity ([@b177]), outer membrane ultrastructure ([@b179], [@b180]), protein content ([@b57]; [@b25]; [@b198]), and fatty acid composition ([@b77]; [@b111]; [@b64], [@b65]).

###### 

Mechanisms conferring biocide resistance in bacteria

  Mechanism                                  Effect                                                                       Example of structures (and microorganisms)
  ------------------------------------------ ---------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Decrease in biocide concentration*                                                                                     
  Impermeability barrier                     Decrease the amount of a biocide that penetrates in the cell                 Spore coats (bacterial spores), LPS (Gram-negative bacteria), mycoylarabinogalactan layer (mycobacteria)
  Multidrug efflux pumps                     Decrease the amount of a biocide within the cell                             QacA-D, QacG and QacH, Nor A (*Staphylococcus aureus*), MexAB-OprM, MexCD-OprJ, MexEF-OprN, MexJK, QacE, QacΔ1 (*Pseudomonas aeruginosa*), QacE, SilABC (*Klebsiella pneumoniae*), AcrAB-TolC, AcrEF-TolC, EmrE (*Escherichia coli*)
  Degradation                                Inactivate a biocide outside or within a cell                                Hydrolase and reductase (*E. coli; S. aureus*), aldehyde dehydrogenase (*E. coli, P. aeruginosa*), catalases, superoxide dismutase and alkyl hydroxyperoxidases[a](#tf4-1){ref-type="table-fn"} (*E. coli*)
  *Alteration of target(s) and metabolism*                                                                                
  Modification of target                     Render the effect of a biocide ineffective[b](#tf4-2){ref-type="table-fn"}   Enoyl-acyl carrier reductase (*S. aureus; E. coli; Mycobacterium smegmatis*).
  Multiplication of targets                  Decreases the effective concentration of a biocide                           Interaction with bacterial glycocalyx (in biofilm)
  Alteration of metabolism                   Decrease the detrimental effect of a biocide                                 Phenotypic alteration and "persisters" (bacterial biofilm)

Reduction of free radicals within the cell (eg, following exposure to an oxidising agent);

Has only been observed with the bisphenol triclosan.

Bacteria are also able to decrease the intracellular concentration of toxic compounds by using a range of efflux pumps ([@b119]; [@b126]; [@b91]; [@b100]), which can be divided into five main classes: the small multidrug resistance (SMR) family (now part of the drug/metabolite transporter \[DMT\] superfamily), the major facilitator superfamily (MFS), the ATP-binding cassette (ABC) family, the resistance-nodulation-division (RND) family and the multidrug and toxic compound extrusion (MATE) family ([@b24]; [@b18]; [@b130], [@b131], [@b132]; [@b100]). The involvement of multidrug efflux pumps in bacterial resistance to various compounds including QACs, phenolics, and intercalating agents has been widely reported ([@b183]; [@b94]; [@b95]; [@b87]; [@b72], [@b74]; [@b174]), particularly in *Staphylococcus aureus* with identified pumps such as QacA-D ([@b137]; [@b94]), Smr ([@b97]), QacG ([@b74]), and QacH ([@b73]) and in Gram-negative such as *Pseudomonas aeruginosa*, with MexAB-OprM, MexCD-OprJ, MexEFOprN, and MexJK ([@b161]; [@b34]; [@b115]; [@b132]) and *Escherichia coli* with AcrAB-TolC, AcrEF-TolC, and EmrE ([@b113]; [@b101]; [@b120]; [@b132]) ([Table 4](#tbl4){ref-type="table"}).

Another mechanism that can contribute to the reduction in the concentration of a toxic compound is degradation ([Table 4](#tbl4){ref-type="table"}). Degradation has been well described for metallic salts with an enzymatic reduction ([@b35]) and for aldehydes with the involvement of aldehydes dehydrogenase ([@b82]). The degradation of phenols, such as triclosan, by environmental strains ([@b76]) has been reported, but there is little evidence that such degradation takes place in clinical isolates. In addition, some bacteria express enzymes such as catalases, superoxide dismutase, and alkyl hydroxyperoxidases to prevent and repair free radical-induced damage caused by oxidizing agents ([@b44]).

Finally, although the modification of a target site is a well-known mechanism of bacterial resistance to antibiotics ([@b32]), it does not usually occur with biocide -- with possibly one exception, the bisphenol triclosan. This phenolic compound has been shown to interact specifically with an enoyl-acyl reductase carrier protein ([@b69]; [@b92], [@b138]; [@b170]), the modification of which was associated with low-level bacterial resistance to this compound ([@b103]; [@b70]; [@b124]). The inhibition of the fatty acid biosynthesis might be involved in the growth-inhibitory effect of triclosan, but other mechanisms were involved in its lethal activity ([@b62]).

Some of the mechanisms described above are intrinsic to the microorganisms; ie, a natural property. The acquisition of resistance is of notable concern since a previously sensitive microorganism can become insusceptible to a biocide ([@b144]) or a group of antimicrobials through, eg, the acquisition of multidrug resistant determinants ([@b97]; [@b165]; [@b80]; [@b15]). Acquired resistance can arise through several processes, eg, mutations, the amplification of an endogenous chromosomal gene, and the acquisition of genetic determinants ([@b97]; [@b125]; [@b131]).

Phenotypic variations resulting from biocidal exposure might lead to bacterial resistance ([@b30]) and this is now well supported by documented laboratory evidence. This is an issue since phenotypic alterations can lead to the emergence of resistance to several unrelated compounds in vitro ([@b192]; [@b185]). Phenotypic variation and antimicrobial resistance also concern bacterial biofilms, which are increasingly associated with bacterial contamination and infection, eg, implants, catheters, and other medical devices ([@b37]; [@b38]; [@b158]; [@b60]; [@b123]). Bacteria in biofilms have been shown to be more resistant to antimicrobials than their planktonic counterparts ([@b4]). Resistance results from a multicomponent mechanism involving phenotypic adaptation following attachment to surfaces ([@b23]; [@b5]; [@b43]), impairment of biocide penetration, and enzymatic inactivation ([@b167]; [@b61]; [@b75]; [@b58]), and the induction of multidrug resistance operons and efflux pumps ([@b107]).

Emergence of bacterial resistance to biocides and antibiotics -- evidence from laboratory investigations
--------------------------------------------------------------------------------------------------------

While there is ample evidence from laboratory studies of bacterial adaptation to biocides, linkage to antibiotic resistance is not always clear cut ([@b101], [@b103]; [@b177]; [@b184]; [@b198]; [@b192]; [@b122]). Several laboratory investigations have explored a possible linkage between bacterial resistance to antibiotics and different biocides such as the bisphenol triclosan ([@b113]; [@b101]; [@b33]; [@b39]), the biguanide chlorhexidine ([@b150]; [@b177]), and QACs ([@b3]; [@b192]). Similar mechanisms of resistance have been identified such as impermeability ([@b177]), the induction of multidrug efflux pumps ([@b88]; [@b113]; [@b161]; [@b200]; [@b121]), over expression of multigene components or operons ([@b88]) such as *mar* ([@b113]; [@b101]), *soxRS* and *oxyR* ([@b50]; [@b101]; [@b193]), and the alteration of a target site ([@b103]).

Emergence of bacterial resistance -- evidence from investigations in situ
-------------------------------------------------------------------------

It has been suggested that the use of biocide in healthcare environments leads to the emergence of antibiotic resistance in bacteria, although the evidence in situ is lacking overall ([@b143]) or does not support such a claim ([@b84]). Nevertheless, there have been a number of cases linking biocide usage and emerging antibiotic resistance. For example, the use of silver sulphadiazine for the treatment of burn infection was associated with sulphonamide resistance ([@b96]; [@b20]). Likewise, the use of chlorhexidine scrub-based preoperative showers might be associated with the emergence of methicillin-resistant *S. aureus* (MRSA) ([@b118]). The use of the biguanide in catheters for long-term indwelling catheterization was linked to the emergence of Gram-negative bacteria with multiple antibiotic resistance ([@b171]; [@b173]). The bisphenol triclosan has also been associated with such cross-resistance ([@b33]; [@b90]; [@b2]; [@b160]) although evidence in situ is scarce and recent field investigations failed to make such a link ([@b86]; [@b169]; [@b36]; [@b84]). The heavy use of QACs has also been blamed for the dissemination of *qac* genes and the spread of efflux pumps ([@b126], [@b127]; [@b73], [@b74]; [@b112]; [@b174]), although further evidence is needed to confirm such a link ([@b143]).

Other considerations
--------------------

Biocides are chemical agents that are usually toxic at relatively high concentration, not only for the end user, but also for the environment ([@b48]). The toxicity of some biocides has been particularly well described, eg, the high-level disinfectant glutaraldehyde, the use of which has been associated with dermatitis and occupational asthma ([@b49]; [@b164]; [@b187]). Toxicity and irritation have also been reported with other biocides such as chlorhexidine ([@b188]), povidone iodine ([@b194]), and other disinfectants and antiseptics ([@b175]), although such incidence is infrequent ([@b156]). Hypersensitivity and irritation caused by antiseptics might account for the low compliance in handwashing among healthcare workers ([@b129]). A recent study found that hospital staff using disinfectants might not appreciate the health risks associated with a product ([@b134]).

The future of biocides in the healthcare environment
====================================================

There is no doubt that biocides will continue to play an important role in the prevention of infection in the healthcare environment, although some caution is needed as to their usage and the type of products that should contain antimicrobials. For disinfection and antisepsis purposes, chemical biocides are usually used at high concentrations, exceeding their bacterial minimum inhibitory concentrations many times to achieve a rapid kill. At such concentrations, a biocide will interact with multiple target sites ([@b105]), and the emergence of bacterial resistance is therefore unlikely.

The increased usage of biocide in formulations and products is probably driven by the impetus to control and reduce the spread of HAIs ([@b52]), by an increase in public awareness for microbial infection and contamination, and hygiene ([@b1]; [@b16]; [@b52]), and by strong and profitable commercial interests. The use of such products needs to be balanced between the clear benefit of controlling infection and the potential risk associated with usage, not only in terms of emerging microbial resistance, but also their toxicity and environmental pollution ([@b41]; [@b144]; [@b59]; [@b17]; [@b48]; [@b156]). In this respect, the benefits of using biocides on noncritical surfaces to prevent the transmission of HAIs should be evaluated further ([@b17]). Assessing the role of biocides in controlling nosocomial infection or the value of a disinfection policy is difficult to evaluate in situ, although such information is valuable for the selection of the appropriate regimens ([@b55]). For example, a recent study showed that the use of alcohol hand gel reduced HAIs significantly ([@b199]). For a biocidal formulation/policy to be effective, (1) knowledge of the chemical biocide (ie, activity and limitation), (2) training of end users, and (3) compliance, are essential. It has to be noted that, when possible, physical processing, eg, heat sterilization, offers many advantages over chemical disinfection and should be the method of choice when appropriate ([@b55]). Some authors and institutions have advocated the rotation of biocidal formulations despite a lack of scientific evidence of the benefits of such practice ([@b116]). A clear understanding of the mechanisms of action, the factors affecting their activity, and the problems associated with specific practice is essential and may contribute to the improvement of a biocidal product, in terms of activity, but also usage. For example, improved compliance to hand hygiene in healthcare settings was observed with the introduction of hand rub and alcoholic rub products ([@b129]; [@b19]).

Likewise, understanding of microbial survival to disinfection, limitation, and activity of "chemical sterilants" has led to the commercialization of formulations with improved efficacy for the high-level disinfection of heat-sensitive medical devices ([@b154]; [@b105]).

Finally, there have been some interesting developments in the use of biocides for the treatment and prevention of potential infections. In the dental field, light-activated biocides such as toluidine blue are being explored for the treatment of root canals ([@b189]; [@b197]). In the medical field, the incorporation of biocide combinations (eg, phenolics, metallic salts) into implants ([@b128]), and catheters ([@b66]), and other medical devices ([@b110]; [@b78]) is a fast advancing field of research, although biocide-containing medical devices may be of some concern ([@b110]; [@b172]). Advances in polymer technology and biocidal research will undoubtedly contribute to the emergence of novel biocidal product or biocide-coated/containing medical devices with selected usage and improve efficacy.

Conclusion
==========

The last 50 years have witnessed an important increase in the number of biocides and their usage in the healthcare environment. When used correctly (ie, compliance with disinfection/antisepsis regimens), biocides have an important role to play in controlling infection ([@b85]; [@b143]). There is still some uncertainty as to the extent of their use in the healthcare environment. Should they be reserved for the disinfection of critical and semi-critical items/areas only, or should they be used also on noncritical devices/surfaces? Should the use of biocide-embedded products (eg, plastics, fabrics) be encouraged or banned? There is no doubt that the use of chemical biocides creates a selective pressure. However, it is yet unclear in practice whether such pressure favors the emergence of bacterial resistance. It is pertinent to note that the development of antibiotic resistance as a result of the selective pressure exerted by their intensive use, and sometimes misuse, is well documented ([@b195]). Monitoring the susceptibility profile of hospital isolates to biocides might therefore be indicated. This would provide useful information as to whether bacterial survival in the healthcare setting following exposure to chemical biocides results from the bacterial resistance mechanisms (eg, biofilm persistence) or from disinfection failure following inappropriate usage. More research is needed to better assess the effect and efficacy of biocidal policies in practice.

This paper focused mainly on bacterial infection and did not expend on infection/contamination caused by other microorganisms such as viruses, fungi, and prions. Among these microorganisms, prions are the most resistant to biocides and when the presence of these agents is suspected, the use of single-use items is recommended. If this is not possible, special sterilization regimens should be employed ([@b182]; [@b181]; [@b53]; [@b157]). Nonenveloped viruses might also be particularly resilient to disinfection ([@b104], [@b106]), although the virucidal efficacy of biocides and biocidal policies in situ is poorly documented. Again, more investigation is needed to gain a better understanding of the survival capabilities of these microorganisms in the healthcare environment following disinfection.

Biocides are essential in preventing and controlling infections in the healthcare environment and the benefits from their usage currently outweigh possible disadvantages ([@b156]). Disinfection of noncritical surfaces and items, and the usage of biocide-containing products, need to be reviewed, although the incorporation of biocides into medical devices to prevent bacterial infection is promising, if controlled and assessed appropriately.
